Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Acquisitions (2024)

Nuvation Bio (NUVB-WT) has disclosed Acquisitions for 1 consecutive years, with -$1000.0 as the latest value for Q4 2024.

  • Quarterly Acquisitions changed N/A to -$1000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$1000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $19.9 million for FY2024, N/A changed from the prior year.
  • Acquisitions for Q4 2024 was -$1000.0 at Nuvation Bio.
  • The five-year high for Acquisitions was -$1000.0 in Q4 2024, with the low at -$1000.0 in Q4 2024.